newsfilter
← Latest News
GlobeNewswire·

Orgenesis Schedules Fourth Quarter 2022 Business Update Conference Call

GERMANTOWN, Md., March 17, 2023 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ:ORGS) ("Orgenesis" or the "Company"), a global biotech company working to unlock the full potential of cell and gene therapies, today announced